tPA for stroke: important progress in achieving faster treatment

Affiliations

Editorial

James C Grotta. JAMA. 2014 Apr.

. 2014 Apr;311(16):1615-7.

doi: 10.1001/jama.2014.3322.

¹ Memorial Hermann Hospital, Clinical Innovation and Research Institute, Houston, Texas.

No abstract available

Comment on

Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial.
Ebinger M, Winter B, Wendt M, Weber JE, Waldschmidt C, Rozanski M, Kunz A, Koch P, Kellner PA, Gierhake D, Villringer K, Fiebach JB, Grittner U, Hartmann A, Mackert BM, Endres M, Audebert HJ; STEMO Consortium. Ebinger M, et al. JAMA. 2014 Apr 23-30;311(16):1622-31. doi: 10.1001/jama.2014.2850. JAMA. 2014. PMID: 24756512 Clinical Trial.
Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
Fonarow GC, Zhao X, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Xian Y, Hernandez AF, Peterson ED, Schwamm LH. Fonarow GC, et al. JAMA. 2014 Apr 23-30;311(16):1632-40. doi: 10.1001/jama.2014.3203. JAMA. 2014. PMID: 24756513